Filter by theme
Paddy Moriarty, a volunteer from Northern Ireland, shares his experience of volunteering.
The European Stroke Organisation Conference (ESOC) 2018 took place between 16-18 May in Gothenburg, Sweden. The third day of ESOC featured new research which identified how to improve stroke care worldwide – from simple measures in low to middle-income countries, through to refinement of advanced techniques for acute and preventative stroke treatments.
The second day of ESOC highlighted the value of collaborations between professional societies and patient representatives for the advancement of stroke care. It saw the launch of the Stroke Action for Europe (2018-2030), a major collaborative initiative between the principal professional and patient organisations setting ambitious targets for stroke care over the next decade.
Presented today at the European Stroke Organisation Conference in Gothenburg, the results of the international WAKE-UP trial suggest that thousands of people who wake up with a stroke each year in the UK could now benefit from life-changing thrombolysis treatment.
Led by the University of Nottingham, a new international study investigated whether patients with a spontaneous bleed in the brain (intracerebral haemorrhage) could benefit from this drug, if delivered as an emergency treatment. An intracerebral haemorrhage is a type of stroke.
The CROMIS-2 study investigated whether signs of small brain bleeds on routine brain scans can help us understand which ischaemic stroke patients with atrial fibrillation are at increased risk of a bleed in the brain when on anticoagulant ‘blood thinning’ drugs.
The European Stroke Organisation Conference (ESOC) 2018 is currently on from 16-18 May in Gothenburg, Sweden. The first day of ESOC included some truly inspiring scientific sessions, including the WAKE-UP trial, RIGHT-2 trial and CROMIS-2 trials.